Rozlytrek 200 (Entrectinib Capsule) 200mg

Rozlytrek 200 (Entrectinib) is an oral capsule used for cancer treatment. It targets specific genetic changes in tumors. This medication is prescribed for advanced solid tumors with NTRK gene fusions or ROS1-positive NSCLC. Store at room temperature away from moisture.

Strength

200mg

Pack Size

90s

Storage

Ambient

Manufacturer / TM Owner

Roche Products Pty Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rozlytrek 200 is prescribed to treat certain advanced solid tumors that have specific genetic changes, such as NTRK gene fusions or ROS1-positive non-small cell lung cancer (NSCLC). It is used when cancer has spread or cannot be treated with surgery. This medication helps slow tumor growth by targeting these genetic alterations. Patients should discuss their specific diagnosis with a healthcare provider to confirm suitability.

Side Effects

Rozlytrek 200 works by interfering with the growth signals in cancer cells. Common effects may include fatigue, constipation, or changes in taste. Some patients report mild nausea or dizziness. These effects vary and are typically monitored by a healthcare professional. It is not intended to cure cancer but may help manage disease progression.

Precautions & Warnings

Handle Rozlytrek 200 with care and keep it out of reach of children. Avoid crushing or opening capsules unless instructed. Store in a cool, dry place away from direct sunlight. Report any unusual symptoms to a doctor promptly. Pregnant or breastfeeding individuals should consult a healthcare provider before use.

Avoid Interactions

Rozlytrek 200 may interact with other medications, including strong CYP3A inhibitors or inducers. Avoid grapefruit products while taking this medication. Discuss all current prescriptions and supplements with a healthcare provider. Alcohol use should be limited and monitored during treatment.

Frequently Asked Questions

Rozlytrek 200 is used to treat advanced solid tumors with specific genetic changes, such as NTRK gene fusions or ROS1-positive NSCLC.

Store Rozlytrek 200 at room temperature in a dry place away from moisture and direct sunlight.

Do not open or crush the capsule unless instructed by a healthcare provider.

Common effects may include fatigue, constipation, nausea, or changes in taste.

Yes, it may interact with CYP3A inhibitors or inducers; consult a doctor before combining treatments.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.